Structures by: Dubois J.
Total: 22
C16H21Br
C16H21Br
Organic letters (2017) 19, 18 4766-4769
a=19.772(2)Å b=6.1368(7)Å c=23.6786(19)Å
α=90° β=94.152(8)° γ=90°
C17H23BrO
C17H23BrO
Organic letters (2017) 19, 18 4766-4769
a=7.4193(10)Å b=12.1143(13)Å c=17.167(2)Å
α=90° β=90° γ=90°
C17H23Br
C17H23Br
Organic letters (2017) 19, 18 4766-4769
a=7.4409(5)Å b=10.1018(12)Å c=11.3589(9)Å
α=68.534(9)° β=75.635(7)° γ=69.502(9)°
C18H20O5
C18H20O5
Journal of medicinal chemistry (2009) 52, 14 4538-4542
a=10.8340(10)Å b=11.6230(10)Å c=13.5110(10)Å
α=90.00(5)° β=104.00(5)° γ=90.00(5)°
C30H32N2O5
C30H32N2O5
Organic & biomolecular chemistry (2019) 17, 10 2798-2808
a=10.4959(12)Å b=20.229(2)Å c=11.8444(14)Å
α=90.00° β=96.215(2)° γ=90.00°
(R)-ethyl 3-((S)-4-benzyl-2-oxooxazolidine-3-carbonyl)hex-5-enoate
C19H23NO5
Organic & Biomolecular Chemistry (2009) 7, 10 2214-2222
a=7.361(3)Å b=10.817(4)Å c=12.310(4)Å
α=90.00° β=106.652(8)° γ=90.00°
(E)-2-methoxy-6-{[(3-nitrophenyl)imino]methyl}phenol
C14H12N2O4
CrystEngComm (2015) 17, 18 3509
a=4.7895(3)Å b=11.3446(10)Å c=12.0610(9)Å
α=93.472(7)° β=100.357(6)° γ=94.022(6)°
(E)-2-methoxy-6-{[(3-nitrophenyl)imino]methyl}phenol
C14H12N2O4
CrystEngComm (2015) 17, 18 3509
a=12.8418(3)Å b=7.5487(2)Å c=26.4610(6)Å
α=90.00° β=90.00° γ=90.00°
P3-PolymorphI-Pbca
C14H12N2O4
CrystEngComm (2015) 17, 18 3509
a=12.4915(15)Å b=7.5972(14)Å c=26.1737(18)Å
α=90.00° β=90.00° γ=90.00°
C16H13NO2
C16H13NO2
CrystEngComm (2015) 17, 12 2523
a=9.837(2)Å b=16.124(4)Å c=8.643(3)Å
α=90.00° β=90.00° γ=90.00°
4(C17H13NO4),C7H7
4(C17H13NO4),C7H7
CrystEngComm (2015) 17, 12 2523
a=8.3591(3)Å b=10.4196(7)Å c=19.0455(9)Å
α=88.407(5)° β=88.481(3)° γ=76.340(4)°
C14H8Br2N2O5
C14H8Br2N2O5
CrystEngComm (2015) 17, 12 2523
a=9.188(5)Å b=13.284(7)Å c=14.477(8)Å
α=68.21(5)° β=81.24(4)° γ=75.69(4)°
C17H13NO4
C17H13NO4
CrystEngComm (2015) 17, 12 2523
a=8.4040(5)Å b=11.6930(10)Å c=15.2400(10)Å
α=97.881(6)° β=93.354(5)° γ=96.810(6)°
C15H10N2O5
C15H10N2O5
CrystEngComm (2015) 17, 12 2523
a=3.82890(10)Å b=23.3314(7)Å c=7.4554(2)Å
α=90.00° β=98.153(3)° γ=90.00°
C14H6Br2N2O4
C14H6Br2N2O4
CrystEngComm (2015) 17, 12 2523
a=14.8231(9)Å b=7.7177(6)Å c=25.714(2)Å
α=90.00° β=97.692(7)° γ=90.00°
C14H8Br2N2O5
C14H8Br2N2O5
CrystEngComm (2015) 17, 12 2523
a=14.0897(3)Å b=4.81830(10)Å c=22.6757(3)Å
α=90.00° β=90.607(2)° γ=90.00°
C15H10N2O5
C15H10N2O5
CrystEngComm (2015) 17, 12 2523
a=6.9750(12)Å b=3.8760(10)Å c=23.998(3)Å
α=90.00° β=91.227(12)° γ=90.00°
C8H5NO6,C7H9N
C8H5NO6,C7H9N
CrystEngComm (2015) 17, 12 2523
a=59.519(2)Å b=12.942(5)Å c=7.623(2)Å
α=90.00° β=90.00° γ=90.00°
11-12 dihydro, 7-triethylsilyl, 10-deacetylbaccatin III.
C35H52O10Si
Acta Crystallographica Section C (1995) 51, 10 2050-2053
a=8.517(6)Å b=15.512(9)Å c=25.925(14)Å
α=90.00° β=90.00° γ=90.00°
3-<i>tert</i>-Butyl 5-methyl (2<i>R</i>,4<i>S</i>,5<i>R</i>)- 2-(4-methoxyphenyl)-4-(3-nitrophenyl)-1,3-oxazolidine-3,5-dicarboxylate
C23H26N2O8
Acta Crystallographica Section E (2012) 68, 11 o3146-o3147
a=10.3830(10)Å b=6.0303(6)Å c=18.7366(17)Å
α=90.00° β=95.591(4)° γ=90.00°